关注
Munmun Rahman
Munmun Rahman
未知所在单位机构
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
A Katagiri, K Nakayama, MT Rahman, M Rahman, H Katagiri, ...
Modern Pathology 25 (2), 282, 2012
2312012
EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target
K Iida, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ...
British journal of cancer 105 (3), 420, 2011
1012011
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma
M Rahman, K Nakayama, MT Rahman, N Nakayama, M Ishikawa, ...
Human pathology 43 (12), 2197-2206, 2012
732012
Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer
MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ...
American journal of clinical pathology 138 (4), 535-544, 2012
672012
Prognostic and therapeutic impact of the chromosome 20q13. 2 ZNF217 locus amplification in ovarian clear cell carcinoma
MT Rahman, K Nakayama, M Rahman, N Nakayama, M Ishikawa, ...
Cancer 118 (11), 2846-2857, 2012
652012
Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes
S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, K Iida, ...
Gynecologic oncology 117 (3), 409-416, 2010
622010
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
K Nakayama, MT Rahman, M Rahman, K Nakamura, M Ishikawa, ...
International journal of oncology 48 (2), 506-516, 2016
612016
PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes
M Rahman, K Nakayama, MT Rahman, N Nakayama, H Katagiri, ...
Anticancer research 33 (1), 113-118, 2013
512013
Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas
S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ...
Human pathology 43 (4), 506-519, 2012
492012
Biological role and prognostic significance of NAC1 in ovarian cancer
K Nakayama, MT Rahman, M Rahman, S Yeasmin, M Ishikawa, A Katagiri, ...
Gynecologic oncology 119 (3), 469-478, 2010
452010
Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer
MT Rahman, K Nakayama, M Ishikawa, M Rahman, H Katagiri, A Katagiri, ...
Oncology 84 (3), 166, 2013
412013
Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas
MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ...
British journal of cancer 107 (2), 300, 2012
402012
Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
M Rahman, K Nakayama, MT Rahman, H Katagiri, A Katagiri, T Ishibashi, ...
Human pathology 44 (1), 103-109, 2013
392013
Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition
S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ...
International journal of cancer 128 (1), 94-104, 2011
362011
Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix
A Katagiri, K Nakayama, MT Rahman, M Rahman, H Katagiri, M Ishikawa, ...
International Journal of Gynecological Cancer 22 (2), 208-212, 2012
332012
KRAS and MAPK1 gene amplification in type II ovarian carcinomas
MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ...
International journal of molecular sciences 14 (7), 13748-13762, 2013
312013
Gene amplification of ZNF217 located at chr20q13. 2 is associated with lymph node metastasis in ovarian clear cell carcinoma
MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ...
Anticancer research 32 (8), 3091-3095, 2012
282012
Microwave endometrial ablation is a highly efficacious way to emergently control life-threatening uterine hemorrhage
K Nakayama, MT Rahman, M Rahman, M Ishikawa, S Yeasmin, A Katagiri, ...
Archives of gynecology and obstetrics 283 (5), 1065-1068, 2011
232011
MKK4 acts as a potential tumor suppressor in ovarian cancer
S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ...
Tumor Biology 32 (4), 661-670, 2011
222011
ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysis
MT Rahman, K Nakayama, M Rahman, M Ishikawa, H Katagiri, A Katagiri, ...
Anticancer research 33 (9), 3775-3781, 2013
182013
系统目前无法执行此操作,请稍后再试。
文章 1–20